Beijing Strong Biotechnologies, Inc. (300406.SZ)
CNY 14.0
(0.65%)
CNY 14.0
(0.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 229.74 Million CNY | 4.6% |
| 2022 | 219.65 Million CNY | -12.84% |
| 2021 | 252 Million CNY | 1.84% |
| 2020 | 247.44 Million CNY | 65.49% |
| 2019 | 149.52 Million CNY | 31.45% |
| 2018 | 113.74 Million CNY | -4.81% |
| 2017 | 119.49 Million CNY | 22.72% |
| 2016 | 97.37 Million CNY | 4.18% |
| 2015 | 93.46 Million CNY | 13.02% |
| 2014 | 82.69 Million CNY | 29.78% |
| 2013 | 63.72 Million CNY | 18.8% |
| 2012 | 53.63 Million CNY | 31.45% |
| 2011 | 40.8 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 236.85 Million CNY | 3.09% |
| 2024 Q3 | 236.17 Million CNY | 4.75% |
| 2024 Q2 | 225.47 Million CNY | -4.8% |
| 2023 Q3 | 230.19 Million CNY | 4.91% |
| 2023 Q4 | 229.74 Million CNY | -0.2% |
| 2023 Q1 | 241.2 Million CNY | 9.81% |
| 2023 Q2 | 219.41 Million CNY | -9.03% |
| 2023 FY | 229.74 Million CNY | 4.6% |
| 2022 Q4 | 219.65 Million CNY | -4.65% |
| 2022 FY | 219.65 Million CNY | -12.84% |
| 2022 Q2 | 227.18 Million CNY | 2.84% |
| 2022 Q1 | 220.9 Million CNY | -12.34% |
| 2022 Q3 | 230.36 Million CNY | 1.4% |
| 2021 Q4 | 252 Million CNY | 4.44% |
| 2021 Q1 | 239.2 Million CNY | -3.33% |
| 2021 Q2 | 230.58 Million CNY | -3.6% |
| 2021 FY | 252 Million CNY | 1.84% |
| 2021 Q3 | 241.29 Million CNY | 4.65% |
| 2020 Q4 | 247.44 Million CNY | -2.94% |
| 2020 Q3 | 254.94 Million CNY | 30.99% |
| 2020 Q2 | 194.62 Million CNY | 7.64% |
| 2020 Q1 | 180.8 Million CNY | 20.92% |
| 2020 FY | 247.44 Million CNY | 65.49% |
| 2019 Q2 | 141.13 Million CNY | 23.32% |
| 2019 Q4 | 149.52 Million CNY | -3.23% |
| 2019 Q1 | 114.43 Million CNY | 0.61% |
| 2019 FY | 149.52 Million CNY | 31.45% |
| 2019 Q3 | 154.51 Million CNY | 9.49% |
| 2018 Q3 | 128.32 Million CNY | 4.81% |
| 2018 FY | 113.74 Million CNY | -4.81% |
| 2018 Q4 | 113.74 Million CNY | -11.36% |
| 2018 Q2 | 122.42 Million CNY | -0.07% |
| 2018 Q1 | 122.5 Million CNY | 2.52% |
| 2017 Q3 | 124.62 Million CNY | 14.04% |
| 2017 Q4 | 119.49 Million CNY | -4.12% |
| 2017 FY | 119.49 Million CNY | 22.72% |
| 2017 Q1 | 98.41 Million CNY | 1.07% |
| 2017 Q2 | 109.28 Million CNY | 11.05% |
| 2016 Q2 | 117.28 Million CNY | 11.29% |
| 2016 Q4 | 97.37 Million CNY | -6.5% |
| 2016 FY | 97.37 Million CNY | 4.18% |
| 2016 Q1 | 105.38 Million CNY | 12.75% |
| 2016 Q3 | 104.13 Million CNY | -11.21% |
| 2015 Q2 | 84.17 Million CNY | -6.11% |
| 2015 Q4 | 93.46 Million CNY | -6.66% |
| 2015 Q3 | 100.13 Million CNY | 18.96% |
| 2015 Q1 | 89.64 Million CNY | 8.4% |
| 2015 FY | 93.46 Million CNY | 13.02% |
| 2014 Q2 | 77.96 Million CNY | 0.0% |
| 2014 Q4 | 82.69 Million CNY | -8.18% |
| 2014 Q3 | 90.06 Million CNY | 15.53% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 FY | 82.69 Million CNY | 29.78% |
| 2013 Q4 | 63.72 Million CNY | 0.0% |
| 2013 FY | 63.72 Million CNY | 18.8% |
| 2012 FY | 53.63 Million CNY | 31.45% |
| 2011 FY | 40.8 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 84.775% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -881.913% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | 59.9% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | 11.299% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 74.683% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | 34.62% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -130.765% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 61.848% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -698.206% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | 37.52% |